The thought of working at an office, dealing with a rigid schedule, and commuting again feels intolerable for some. Working from home during COVID-19 has reshaped how people perceive their careers and maintain work-life balance worldwide. For many remote workers, returning to a traditional 9-to-5 office job was not worth it. Sarah Hesham, a 25-year-old freelance graphic designer, shares the sentiment. After the pandemic forced remote work, Hesham realized how much better her life was without the daily stress of office work and long commutes. She has been working from home for the past four years. A 2022 study by Nashwa Tawfiq from Ain Shams University reports remote work, characterized by flexible hours and structure, is a shift toward a world that is increasingly free from pre-pandemic constraints. Unlike office jobs, remote work eliminates traditional management structures, allowing collaboration to take place in virtual teams. It also reduces strict hierarchies and promotes autonomy, a change that Hesham values. The Perks of Working From Home “The best thing about working from home is the flexibility,” Hesham said. “I get to set my schedule and work during my most productive hours. My…
This content is for members only. Visit the site and log in/register to read.Remote Employees Trade the Office for Autonomy and Productivity first appeared on Egyptian Streets.
Hence then, the article about remote employees trade the office for autonomy and productivity was published today ( ) and is available on Egyptian Streets ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Remote Employees Trade the Office for Autonomy and Productivity )
Also on site :
- Golfer Masashi ‘Jumbo’ Ozaki dies at 78
- Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
- Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline